La Jolla Pharmaceutical Co. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$6.85 |
Market Cap |
$259.88 M |
Shares Outstanding |
27.1 M |
Public Float |
23.14 M |
Address |
4550 Towne Centre Court San Diego California 92121 United States |
Employees | - |
Website | http://www.lajollapharmaceutical.com |
Updated | 07/08/2019 |
La Jolla Pharmaceutical Co. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. Its products includes LJPC-501, LJPC-401, LJPC-30Sa and LJPC-30Sb. LJPC-501 is the proprietary formulation for angiotensin II. |